Biosensor of olfactory receptor nanodisc can be used in disease diagnosis
by detecting disease-relating odorants in the sample collected by non-invasive way.
Development of early stage diagnosis of disesse, such as prostate cancer, ovarian cancer, and Parkinson's can be achieved by RecepTech.
Disesse related GPCR could be a target for both novel antibody therapeutics and chemical drug. Target GPCR in nanodisc form can be utilized in screening novel drug candidates efficiently and effectively.